These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32030882)

  • 1. Genetic screening for hypertrophic cardiomyopathy in large, asymptomatic military cohorts.
    Brough J; Jain M; Jerves T; Kruszka P; McGuffey E
    Am J Med Genet C Semin Med Genet; 2020 Mar; 184(1):124-128. PubMed ID: 32030882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy.
    Mathew J; Zahavich L; Lafreniere-Roula M; Wilson J; George K; Benson L; Bowdin S; Mital S
    Clin Genet; 2018 Feb; 93(2):310-319. PubMed ID: 29053178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.
    Mori AA; Castro LR; Bortolin RH; Bastos GM; Oliveira VF; Ferreira GM; Hirata TDC; Fajardo CM; Sampaio MF; Moreira DAR; Pachón-Mateos JC; Correia EB; Sousa AGMR; Brión M; Carracedo A; Hirata RDC; Hirata MH
    Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?
    Lafreniere-Roula M; Bolkier Y; Zahavich L; Mathew J; George K; Wilson J; Stephenson EA; Benson LN; Manlhiot C; Mital S
    Eur Heart J; 2019 Dec; 40(45):3672-3681. PubMed ID: 31170284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
    Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
    Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
    Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
    Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial Deformation Analysis in
    Höller V; Seebacher H; Zach D; Schwegel N; Ablasser K; Kolesnik E; Gollmer J; Waltl G; Rainer PP; Verheyen S; Zirlik A; Verheyen N
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and ECG variables to predict the outcome of genetic testing in hypertrophic cardiomyopathy.
    Robyns T; Breckpot J; Nuyens D; Vandenberk B; Corveleyn A; Kuiperi C; Van Aelst L; Van Cleemput J; Willems R
    Eur J Med Genet; 2020 Mar; 63(3):103754. PubMed ID: 31513939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
    Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
    Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
    Maron BJ; Maron MS; Semsarian C
    J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.
    Viswanathan SK; Sanders HK; McNamara JW; Jagadeesan A; Jahangir A; Tajik AJ; Sadayappan S
    PLoS One; 2017; 12(11):e0187948. PubMed ID: 29121657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Genetic Basis of Hypertrophic Cardiomyopathy.
    Marian AJ
    Circ Res; 2021 May; 128(10):1533-1553. PubMed ID: 33983830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Utility of a Phenotype-Enhanced
    Mattivi CL; Bos JM; Bagnall RD; Nowak N; Giudicessi JR; Ommen SR; Semsarian C; Ackerman MJ
    Circ Genom Precis Med; 2020 Oct; 13(5):453-459. PubMed ID: 32894683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy.
    Lee SP; Ashley EA; Homburger J; Caleshu C; Green EM; Jacoby D; Colan SD; Arteaga-Fernández E; Day SM; Girolami F; Olivotto I; Michels M; Ho CY; Perez MV;
    Circ Heart Fail; 2018 Sep; 11(9):e005191. PubMed ID: 30354366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    Chiou KR; Chu CT; Charng MJ
    J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment.
    Das K J; Ingles J; Bagnall RD; Semsarian C
    Genet Med; 2014 Apr; 16(4):286-93. PubMed ID: 24113344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.
    Marsiglia JD; Credidio FL; de Oliveira TG; Reis RF; Antunes Mde O; de Araujo AQ; Pedrosa RP; Barbosa-Ferreira JM; Mady C; Krieger JE; Arteaga-Fernandez E; Pereira Ada C
    Am Heart J; 2013 Oct; 166(4):775-82. PubMed ID: 24093860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpectedly low mutation rates in beta-myosin heavy chain and cardiac myosin binding protein genes in Italian patients with hypertrophic cardiomyopathy.
    Roncarati R; Latronico MV; Musumeci B; Aurino S; Torella A; Bang ML; Jotti GS; Puca AA; Volpe M; Nigro V; Autore C; Condorelli G
    J Cell Physiol; 2011 Nov; 226(11):2894-900. PubMed ID: 21302287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
    Núñez L; Gimeno-Blanes JR; Rodríguez-García MI; Monserrat L; Zorio E; Coats C; McGregor CG; Hernandez del Rincón JP; Castro-Beiras A; Hermida-Prieto M
    Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.